Clinical Biomarkers & World CDx Summit 2019

10th Clinical Biomarkers & World CDx Summit is organized by Hanson Wade and will be held from Sep 09 - 12, 2019 at The Westin Boston Waterfront, Boston, Massachusetts, United States of America.

Description:
Returning for the 10th year, Clinical Biomarkers and World CDx Boston is once again the home for the biomarker, translational, diagnostic and precision medicine community to enhance the translation and clinical validation of novel predictive biomarkers, and maximize access and adoption of Dx-enabled therapeutics.

Built for the entire precision medicine industry, from pharma and biotech to Dx, HCPs, regulators and payers, Clinical Biomarkers & World CDx Boston will cover end-to-end the translation, clinical implementation and commercialization of a biomarker strategy to increase market penetration and share. Ultimately, the meeting is here to turn biomarker R&D innovation into better utilization of Dx testing in healthcare – to provide patients with the right treatment decision and most effective therapies at the right time.

For 2019 we have two overarching content themes that underpin the whole meeting:
1. Proving the predictiveness of novel clinical biomarkers to accelerate the development and approval of innovative targeted therapeutics
2. Making diagnostics more fit-for-purpose to increase the adoption and access of Dx-enabled precision medicines in healthcare

The four-day meeting is split into two halves: pre-conference and main conference. Our pre-conference days will contain half-day workshop sessions, designed to take deep, interactive dives into a specific subject area. The main two-day conference is separated into three streams covering translation, clinical development and commercialisation.

Pre-Conference Workshops - September 9-10, 2019
Main Conference - September 11-12, 2019

Time: 9:00 am - 4:00 pm

Additional details will be posted as soon as they are available.